ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.036,13
-1,03%
S&P 500
5.035,69
-1,57%
US Dollar vs BRL
5,1888
1,37%
Bitcoin
59.773,06
-6,36%
Brent Oil
86,015
-1,46%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Daxor Corporation (DXR)

  7. Daxor Corporation (DXR) Notícias

DXR

Daxor (DXR)

Daxor Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:DXR
DataHoraFonteTítuloCódigoCompanhia
21/06/202317:53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:DXRDaxor Corporation
31/05/202313:54Edgar (US Regulatory)Notification of Late Filing of Monthly Portfolio Investments Report on Form N-port (public) (nt Nport-p)AMEX:DXRDaxor Corporation
26/05/202307:02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:DXRDaxor Corporation
16/03/202317:37Edgar (US Regulatory)Annual Report for Registered Investment Companies (n-cen)AMEX:DXRDaxor Corporation
01/03/202319:13Edgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)AMEX:DXRDaxor Corporation
04/01/202317:45Edgar (US Regulatory)Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2/a)AMEX:DXRDaxor Corporation
06/12/202219:20Edgar (US Regulatory)Certificate of Accounting of Securities and Similar Investments in the Custody of Management Investment Companies Filed Pursuant to Rule 17f-2 (40-17f2)AMEX:DXRDaxor Corporation
25/11/202213:17Edgar (US Regulatory)Monthly Portfolio Investments Report on Form N-port (public) (nport-p)AMEX:DXRDaxor Corporation
17/11/202211:01Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)AMEX:DXRDaxor Corporation
14/11/202218:47Edgar (US Regulatory)Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a)AMEX:DXRDaxor Corporation
29/08/202216:47Edgar (US Regulatory)Annual Report of Proxy Voting Record for Management Investment Companies (n-px)AMEX:DXRDaxor Corporation
25/08/202217:07Edgar (US Regulatory)Certified Semi-annual Shareholder Report for Management Investment Companies (n-csrs)AMEX:DXRDaxor Corporation
01/02/202208:45Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)AMEX:DXRDaxor Corporation
01/02/202208:42Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:DXRDaxor Corporation
21/01/202210:00GlobeNewswire Inc.Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of DirectorsAMEX:DXRDaxor Corporation
20/01/202218:05GlobeNewswire Inc.Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022AMEX:DXRDaxor Corporation
06/01/202210:00GlobeNewswire Inc.Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual ConferenceAMEX:DXRDaxor Corporation
05/01/202210:00GlobeNewswire Inc.DAXOR ANNOUNCES KEY MILESTONES ACHIEVED FOR MULTICENTER BVA-100® STUDY IN HOSPITALIZED PATIENTS WITH COVID-19AMEX:DXRDaxor Corporation
04/01/202210:00GlobeNewswire Inc.DAXOR AWARDED NEW PATENT FOR BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESAMEX:DXRDaxor Corporation
16/11/202110:00GlobeNewswire Inc.Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Optimal Heart Failure Management at Key Scientific Society MeetingAMEX:DXRDaxor Corporation
09/11/202110:00GlobeNewswire Inc.New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100®) Diagnostic in Neurocritical CareAMEX:DXRDaxor Corporation
01/10/202109:30GlobeNewswire Inc.Daxor Corporation Receives $200K Matching Fund Award from Launch TennesseeAMEX:DXRDaxor Corporation
15/09/202118:30Edgar (US Regulatory)Amendment to Annual Report for Registered Investment Companies (n-cen/a)AMEX:DXRDaxor Corporation
14/09/202109:30GlobeNewswire Inc.Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society MeetingAMEX:DXRDaxor Corporation
08/09/202109:30GlobeNewswire Inc.Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021AMEX:DXRDaxor Corporation
07/09/202109:30GlobeNewswire Inc.Daxor Corporation to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual ConferenceAMEX:DXRDaxor Corporation
01/09/202109:30GlobeNewswire Inc.Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersAMEX:DXRDaxor Corporation
30/08/202109:30GlobeNewswire Inc.Daxor Corporation Reports a 26.5 Percent Rise in Diagnostic Sales Revenue in Form N-CSR Filing for the Six Months Ended June 30, 2021AMEX:DXRDaxor Corporation
04/08/202109:30GlobeNewswire Inc.Daxor’s Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly Published Data in Journal Critical CareAMEX:DXRDaxor Corporation
22/07/202109:30GlobeNewswire Inc.DAXOR CORPORATION ANNOUNCES NON-GOVERNMENT DISTRIBUTION AGREEMENT WITH CONCORDANCE® HEALTHCARE SOLUTIONSAMEX:DXRDaxor Corporation
 Apresentando as notícias mais relevantes sobre:AMEX:DXR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
TECN3
TECHNOS ON
BOV
EMAE4
EMAE PN
BOV
GOLL4
GOL PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
OIBR3
OI ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
COGN3
COGNA ON
BOV
HBOR3
HELBOR ON
BOV
HAGA3
HAGA ON
BOV
SGPS3
SPRINGS ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
BRKM5
BRASKEM PNA
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
LUPA3
LUPATECH ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados